Publicaciones en colaboración con investigadoras/es de Hospital de Cruces (26)

2024

  1. Lipid fingerprint-based histology accurately classifies nevus, primary melanoma, and metastatic melanoma samples

    International Journal of Cancer, Vol. 154, Núm. 4, pp. 712-722

2023

  1. Delta and kappa opioid receptors in human endometrium during the menstrual cycle: Expression and localization

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 283, pp. 68-73

  2. Isolation and Differentiation of Neurons and Glial Cells from Olfactory Epithelium in Living Subjects

    Molecular Neurobiology, Vol. 60, Núm. 8, pp. 4472-4487

2022

  1. In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study

    Frontiers in Cellular and Infection Microbiology, Vol. 12

  2. Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability

    Antibiotics, Vol. 11, Núm. 5

  3. Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis

    Parkinsonism and Related Disorders, Vol. 99, pp. 107-115

2021

  1. Oral and Palmitate Paliperidone Long-Acting Injectable Formulations' Use in Schizophrenia Spectrum Disorders: A Retrospective Cohort Study from the First Episode Psychosis Intervention Program (CRUPEP)

    International Journal of Neuropsychopharmacology, Vol. 24, Núm. 9, pp. 694-702

2019

  1. Fractures Related to Tenofovir: A Case/Noncase Study in the European Pharmacovigilance Database

    American journal of therapeutics, Vol. 26, Núm. 5, pp. e589-e592

2017

  1. Building Bridges through Science

    Neuron

2015

  1. Dynamics of expression and localization of the cannabinoid system in granulosa cells during oocyte nuclear maturation

    Fertility and Sterility, Vol. 104, Núm. 3, pp. 753-760

2013

  1. Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: Pharmacokinetic considerations and patient pathophysiology

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 51, Núm. 7, pp. 606-614

  2. Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction

    European Journal of Clinical Pharmacology, Vol. 69, Núm. 1, pp. 65-74

2012

  1. Effect of synthetic cannabinoid CB1 agonist (WIN 55212-2) and antagonist (AM 251) on intraocular pressure in rats

    Glaucoma: Etiology, Pathogenesis and Treatments (Nova Science Publishers, Inc.), pp. 147-156

2011

  1. Pathophysiological idiosyncrasies and pharmacokinetic realities may interfere with tacrolimus dose titration in liver transplantation

    European Journal of Clinical Pharmacology, Vol. 67, Núm. 7, pp. 671-679

2010

  1. Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas

    Neurochemistry International, Vol. 56, Núm. 6-7, pp. 829-833

2008

  1. Monoamine oxidase B activity is increased in human gliomas

    Neurochemistry International, Vol. 52, Núm. 1, pp. 230-234

  2. Specific binding of [3H]Ro 19-6327 (lazabemide) to monoamine oxidase B is increased in frontal cortex of suicide victims after controlling for age at death

    European Neuropsychopharmacology, Vol. 18, Núm. 1, pp. 55-61

2007

  1. An independent meta-analysis using summary data for clinical response, remission, and discontinuation for any reason from the 6 pivotal phase III randomized clinical trials of duloxetine in major depressive disorder [10]

    Journal of Clinical Psychopharmacology

2006

  1. Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: Effects of subthalamotomy and levodopa treatment

    Brain Research, Vol. 1084, Núm. 1, pp. 175-184

  2. Greater allergenicity of topical ketoprofen in contact dermatitis confirmed by use

    Contact Dermatitis, Vol. 54, Núm. 5, pp. 239-243